1 |
Zhou P, Gao G, Zhao CC, Li JY, Peng JF, Wang SS, Song R, Shi H, Wang L. In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity. Pharm Biol 2022;60:638-51. [PMID: 35298357 DOI: 10.1080/13880209.2022.2046801] [Reference Citation Analysis]
|
2 |
Xu X, Yang Y, Zhou G, Du Z, Zhang X, Mao W, Cai H. Clinical Efficacy of Qili Qiangxin Capsule Combined with Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2021;2021:9761159. [PMID: 34408783 DOI: 10.1155/2021/9761159] [Reference Citation Analysis]
|
3 |
Zhang X, Zhang J, Ji X, Wei Z, Ding B, Liu G, Lv X, Zheng Y, Zhan S. A Quantitative Serum Proteomic Analysis Helps to Explore the Comprehensive Mechanism and Identify Serum Biomarkers of Shengmai Injection's Effect on Isoproterenol-Induced Myocardial Ischemia in Rats. Front Pharmacol 2021;12:666429. [PMID: 33995093 DOI: 10.3389/fphar.2021.666429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Wang C, Liu A, Wu H, Yang Y. Prediction the Molecular Mechanism of Shengmai Injection in Acute Treatment of COVID-19 Based on Network Pharmacology. Natural Product Communications 2022;17:1934578X2210750. [DOI: 10.1177/1934578x221075075] [Reference Citation Analysis]
|
5 |
Liu YW, Hsu YT, Lee WC, Tsai MY. Review of Traditional Chinese Medicines for Common Complications Related to Hemodialysis: An Evidence-Based Perspective. Evid Based Complement Alternat Med 2021;2021:9953986. [PMID: 34335848 DOI: 10.1155/2021/9953986] [Reference Citation Analysis]
|